1-4 of 4
Uta Bertsch
Close
Sort by
Journal Articles

Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM

Clinical Trials & Observations
Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias K. Mai, Marc S. Raab, Hans J. Salwender, Roland Fenk, Britta Besemer, Jan Dürig, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Anne M. Asemissen, Bernhard Heilmeier, Uta Bertsch, Stefanie Huhn, Carsten Müller-Tidow, Hartmut Goldschmidt, Michael Hundemer
Journal: Blood Advances
Blood Adv (2023) 7 (3): 379–383.
https://doi.org/10.1182/bloodadvances.2022008005
Published: 2023
Includes: Supplemental data
Journal Articles

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Clinical Trials & Observations
Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann
Journal: Blood Advances
Blood Adv (2022) 6 (2): 515–520.
https://doi.org/10.1182/bloodadvances.2021005532
Published: 2022
Includes: Supplemental data
Journal Articles

A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis

Clinical Trials & Observations
Julie Støve Bødker, Rasmus Froberg Brøndum, Alexander Schmitz, Anna Amanda Schönherz, Ditte Starberg Jespersen, Mads Sønderkær, Charles Vesteghem, Hanne Due, Caroline Holm Nørgaard, Martin Perez-Andres, Mehmet Kemal Samur, Faith Davies, Brian Walker, Charlotte Pawlyn, Martin Kaiser, David Johnson, Uta Bertsch, Annemiek Broyl, Mark van Duin, Rajen Shah, Preben Johansen, Martin Agge Nørgaard, Richard J. Samworth, Pieter Sonneveld, Hartmut Goldschmidt, Gareth J. Morgan, Alberto Orfao, Nikhil Munshi, Hans Erik Johnsen, Tarec El-Galaly, Karen Dybkær, Martin Bøgsted
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2400–2411.
https://doi.org/10.1182/bloodadvances.2018018564
Published: 2018
Includes: Supplemental data
Journal Articles

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Maximilian Merz, Anna Jauch, Thomas Hielscher, Tilmann Bochtler, Stefan Olaf Schönland, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc Steffen Raab, Jens Hillengass, Hans Salwender, Igor Wolfgang Blau, Hans-Walter Lindemann, Ingo G. H. Schmidt-Wolf, Christof Scheid, Mathias Haenel, Katja C. Weisel, Hartmut Goldschmidt
Journal: Blood Advances
Blood Adv (2017) 2 (1): 1–9.
https://doi.org/10.1182/bloodadvances.2017013334
Published: 2017
Includes: Supplemental data